Range Low Price High Price Comment
30 days $142.01 $158.06 Thursday, 28th Mar 2024 ASND stock ended at $151.17. This is 1.84% more than the trading day before Wednesday, 27th Mar 2024. During the day the stock fluctuated 4.79% from a day low at $144.66 to a day high of $151.59.
90 days $119.03 $161.00
52 weeks $64.33 $161.00

Historical Ascendis Pharma A/S prices

Date Open High Low Close Volume
2022-05-05 $93.07 $94.31 $88.83 $90.22 404 221
2022-05-04 $91.93 $94.60 $88.07 $94.22 568 718
2022-05-03 $91.01 $93.64 $89.76 $92.10 272 755
2022-05-02 $90.82 $95.76 $89.76 $91.05 488 516
2022-04-29 $97.51 $99.89 $89.34 $91.27 733 558
2022-04-28 $104.91 $105.22 $97.60 $98.50 954 023
2022-04-27 $104.31 $105.70 $103.00 $103.28 262 876
2022-04-26 $107.21 $107.89 $102.19 $103.22 566 829
2022-04-25 $105.28 $109.21 $105.25 $108.29 476 547
2022-04-22 $106.33 $108.10 $104.80 $105.92 304 100
2022-04-21 $110.20 $110.83 $105.30 $106.05 446 000
2022-04-20 $110.13 $110.80 $108.11 $109.59 167 700
2022-04-19 $106.96 $111.11 $106.00 $109.78 238 800
2022-04-18 $112.75 $112.75 $105.93 $107.15 943 200
2022-04-14 $115.29 $115.29 $111.98 $112.96 372 419
2022-04-13 $109.69 $115.52 $107.94 $115.52 352 336
2022-04-12 $107.41 $110.65 $106.44 $108.84 640 640
2022-04-11 $110.75 $110.87 $105.06 $106.34 316 303
2022-04-08 $112.23 $115.41 $110.76 $111.21 299 827
2022-04-07 $117.40 $119.94 $111.26 $114.28 512 400
2022-04-06 $114.03 $119.07 $113.04 $117.61 398 300
2022-04-05 $117.36 $120.34 $114.87 $115.73 363 300
2022-04-04 $116.22 $120.69 $115.28 $117.40 255 400
2022-04-01 $117.76 $119.68 $114.04 $115.92 476 689
2022-03-31 $115.83 $118.93 $115.26 $117.28 439 926
Click to get the best stock tips daily for free!

About Ascendis Pharma A/S

Ascendis Pharma A/S Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops Tra... ASND Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT